Literature DB >> 17362452

Fungal keratitis in Melbourne.

Prashant Bhartiya1, Mark Daniell, Marios Constantinou, F M Amirul Islam, Hugh R Taylor.   

Abstract

BACKGROUND: Description of the clinical and microbiological spectrum of fungal keratitis at a tertiary eye care hospital in Melbourne, Australia.
METHODS: Retrospective review of all patients with keratitis with positive fungal cultures from corneal or associated samples presenting to the Royal Victorian Eye and Ear Hospital, Melbourne, Australia from July 1996 to May 2004. Demographic data, predisposing factors, features on presentation, management, outcomes and microbiological data were collected and analysed.
RESULTS: The study included 56 eyes of 56 patients. Thirty-five patients were treated as 'typical' fungal keratitis and used for description and analysis, with a mean follow up of 18 months. Ocular trauma (37.1%), chronic steroid use (31.4%) and poor ocular surface (25.7%) were the major predisposing factors. Perforation was seen in 25.7% of patients, penetrating keratoplasty was required in 9 (25.7%) patients and evisceration was performed in 2 (5.7%) patients. Candida albicans (13 patients, 37.2%) was the most common fungal isolate accounting for more than one-third of all organisms followed by Aspergillus fumigatus (six patients, 17.1%) and Fusarium sp. (five patients, 14.3%).
CONCLUSIONS: The present study describes the clinical patterns of fungal keratitis in Melbourne, Australia and contrasts them with reports from other areas of the world. A high incidence of C. albicans infection and the prior use of steroids in high proportion of the patients are highlighted in this study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17362452     DOI: 10.1111/j.1442-9071.2006.01405.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  29 in total

1.  Characterization of fusarium keratitis outbreak isolates: contribution of biofilms to antimicrobial resistance and pathogenesis.

Authors:  Pranab K Mukherjee; Jyotsna Chandra; Changping Yu; Yan Sun; Eric Pearlman; Mahmoud A Ghannoum
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-03       Impact factor: 4.799

Review 2.  The role of cytokines and pathogen recognition molecules in fungal keratitis - Insights from human disease and animal models.

Authors:  Sixto M Leal; Eric Pearlman
Journal:  Cytokine       Date:  2012-01-26       Impact factor: 3.861

3.  Prospective open-label study of the administration of two-percent voriconazole eye drops.

Authors:  Daoud Al-Badriyeh; Lok Leung; Trent Roydhouse; Robert Fullinfaw; Mark Daniell; Geoffrey E Davies; Kay Stewart; David C M Kong
Journal:  Antimicrob Agents Chemother       Date:  2009-05-11       Impact factor: 5.191

4.  Stability of extemporaneously prepared 0.5-percent caspofungin eye drops: a potential cost-savings exercise.

Authors:  Chin Fen Neoh; Jovan Jacob; Lok Leung; Jian Li; Angela Stathopoulos; Kay Stewart; David C M Kong
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

5.  Spectrum of fungal keratitis: clinicopathologic study of 44 cases.

Authors:  Rajpal Singh Punia; Reetu Kundu; Jagdish Chander; Sudesh Kumar Arya; Uma Handa; Harsh Mohan
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

Review 6.  Corneal blindness and xenotransplantation.

Authors:  Vladimir Lamm; Hidetaka Hara; Alex Mammen; Deepinder Dhaliwal; David K C Cooper
Journal:  Xenotransplantation       Date:  2014-02-21       Impact factor: 3.907

7.  Fungal antioxidant pathways promote survival against neutrophils during infection.

Authors:  Sixto M Leal; Chairut Vareechon; Susan Cowden; Brian A Cobb; Jean-Paul Latgé; Michelle Momany; Eric Pearlman
Journal:  J Clin Invest       Date:  2012-06-18       Impact factor: 14.808

8.  [The German keratomycosis registry : Initial results of a multicenter survey].

Authors:  M Roth; L Daas; A Renner-Wilde; N Cvetkova-Fischer; M Saeger; M Herwig-Carl; M Matthaei; A Fekete; V Kakkassery; G Walther; M von Lilienfeld-Toal; C Mertens; J Lenk; J Mehlan; C Fischer; M Fuest; S Kroll; W Bayoudh; A Viestenz; A Frings; C R MacKenzie; E M Messmer; B Seitz; O Kurzai; G Geerling
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

9.  Current Thoughts in Fungal Keratitis: Diagnosis and Treatment.

Authors:  Zubair Ansari; Darlene Miller; Anat Galor
Journal:  Curr Fungal Infect Rep       Date:  2013-09-01

10.  Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis.

Authors:  Daoud Al-Badriyeh; Chin Fen Neoh; Kay Stewart; David C M Kong
Journal:  Clin Ophthalmol       Date:  2010-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.